IRIS
Lanzafame, Massimiliano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.820
AS - Asia 1.413
EU - Europa 787
SA - Sud America 329
AF - Africa 58
OC - Oceania 16
Totale 4.423
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.739
SG - Singapore 440
IT - Italia 410
VN - Vietnam 284
CN - Cina 263
BR - Brasile 260
KR - Corea 166
FR - Francia 70
DE - Germania 67
NL - Olanda 60
BD - Bangladesh 46
FI - Finlandia 46
IN - India 43
HK - Hong Kong 41
GB - Regno Unito 40
CA - Canada 37
MX - Messico 28
ZA - Sudafrica 27
AR - Argentina 22
PK - Pakistan 20
IQ - Iraq 19
LV - Lettonia 17
EC - Ecuador 15
TR - Turchia 15
JP - Giappone 14
PL - Polonia 14
AU - Australia 13
ID - Indonesia 13
RU - Federazione Russa 12
MA - Marocco 11
IE - Irlanda 9
SA - Arabia Saudita 9
AT - Austria 7
ES - Italia 7
PE - Perù 7
SE - Svezia 7
UA - Ucraina 7
VE - Venezuela 7
CO - Colombia 6
JO - Giordania 6
PH - Filippine 6
EG - Egitto 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
MY - Malesia 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
UZ - Uzbekistan 4
CR - Costa Rica 3
KE - Kenya 3
NZ - Nuova Zelanda 3
BF - Burkina Faso 2
CH - Svizzera 2
CL - Cile 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
IL - Israele 2
JM - Giamaica 2
NP - Nepal 2
OM - Oman 2
PT - Portogallo 2
SI - Slovenia 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AO - Angola 1
BE - Belgio 1
BG - Bulgaria 1
BJ - Benin 1
BO - Bolivia 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
HU - Ungheria 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
ML - Mali 1
MN - Mongolia 1
MW - Malawi 1
NG - Nigeria 1
PA - Panama 1
QA - Qatar 1
SN - Senegal 1
ST - Sao Tome e Principe 1
SV - El Salvador 1
TW - Taiwan 1
Totale 4.423
Salva come PNG Salva come JPEG
Città #
San Jose 316
Dallas 310
Singapore 258
Ashburn 220
Seoul 165
Ho Chi Minh City 93
Council Bluffs 81
Los Angeles 74
Trento 73
Hanoi 58
Chicago 55
Beijing 48
Lauterbourg 43
Amsterdam 40
New York 40
Hong Kong 38
Helsinki 37
Rome 37
Munich 35
Milan 34
São Paulo 30
Orem 28
Boardman 27
Buffalo 25
Salt Lake City 24
Johannesburg 21
Denver 20
St Louis 19
Santa Clara 18
Cavalese 17
Da Nang 17
Riga 17
Cornedo Vicentino 14
Jinan 14
Mexico City 14
Naples 14
Atlanta 13
Redondo Beach 13
Haiphong 12
Marcianise 12
Phoenix 12
Tokyo 12
Warsaw 12
Karachi 11
London 11
Miano 11
Montreal 11
Chennai 10
Tampa 10
Elk Grove Village 9
Guangzhou 9
Houston 9
Manchester 9
Terrasini 9
Verona 9
Clifton 8
Frankfurt am Main 8
Mumbai 8
Ankara 7
Baghdad 7
Brooklyn 7
Padua 7
Rio de Janeiro 7
Dublin 6
Lancaster 6
North Bergen 6
Pescara 6
Riyadh 6
Toronto 6
Ziano di Fiemme 6
Belo Horizonte 5
Boston 5
Brasília 5
Cairo 5
Canoas 5
Hải Dương 5
Istanbul 5
Kansas City 5
Lahore 5
Nuremberg 5
Salvador 5
San Francisco 5
Seattle 5
Shanghai 5
Stockholm 5
Amman 4
Can Tho 4
City of London 4
Curitiba 4
Dhaka 4
Falkenstein 4
Hefei 4
Hillsboro 4
Miami 4
Newark 4
Poplar 4
Querétaro 4
Roverbella 4
Sydney 4
Tashkent 4
Totale 2.814
Salva come PNG Salva come JPEG
Nome #
Meningite da Escherichia Coli in una persona con infezione da HIV; descrizione di un caso clinico e revisione della letteratura = Escherichia Coli meningitis in a person living with HIV infection: a clinical case and review of the literature. 146
Antibiotic Resistance Patterns Among Uropathogens in Female Outpatients Affected by Uncomplicated Cystitis: Focus on Fosfomycin Trometamol 145
A Precision Medicine Model for Targeted Antibiotic Therapy in Urinary Tract Infections: A Valuable Tool to Reduce Hospitalization Stay and the Time to Switch to Oral Treatment 132
Advances in HIV Treatment: Long-Acting Antiretrovirals and the Path Toward a Cure 99
'High' antiretroviral deintensification strategy and cellular HIV DNA levels 97
A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes 91
Uso degli antibiotici nel fine vita 85
A multicentre real-life prospective cohort study on effectiveness, durability and safety of long-acting injectable cabotegravir and rilpivirine in northern Italy: the LONGITUDE study 85
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 85
Mini-review: Silico-tuberculosis 85
Breastfeeding in women living with HIV in high-income countries: It's time to act 82
Bridging the gap in bloodstream infection management: a survey among non-infectious disease physicians 81
When an underestimated zoonosis and antimicrobial resistance collide: Corynebacterium ulcerans 81
Benign acute viral myositis in African migrants: a clinical, serological and pathological study 78
Prospective analysis of febrile neutropenia patients with bacteraemia: the results of an international ID-IRI study 76
Profiles of primary brain abscesses and their impact on survival: An international ID-IRI study 72
Recurrent UTI: Questions and Answers on Clinical Practice 68
Computational characterization of peptide binding stability to HLA-C allotypes and its association with HIV-1 infection progression and HIV-1 related neurocognitive impairment. 67
Primary cutaneous cryptococcosis in a HIV infested patient: case report 67
Rezafungin Utilisation in Real Life—FungiScope Results From Europe and the United States 66
Treatment of Candida glabrata native valve endocarditis with rezafungin: a case report 65
Emerging strategies in tackling antimicrobial resistance in urology: Narrative review and expert opinion 64
Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study 63
Acceptability of Switching to Long-Acting Cabotegravir and Rilpivirine Among People Living with HIV on Dolutegravir/Rilpivirine Combination: A Single-Center Experience 59
HIV screening of migrants in the autonomous Province of Trento (North-Eastern Italy) 58
High malaria parasitemia in an Italian man and severe delayed hemolytic anemia 57
Relationship between vertebral fractures, bone mineral density, and osteometabolic profile in HIV and Hepatitis B and C-infected patients treated with ART 56
Clinical efficacy of different monoclonal antibody regimens among non-hospitalised patients with mild to moderate COVID-19 at high risk for disease progression: a prospective cohort study 56
The diagnostic yield of the Meares & Stamey test can be significantly improved by symptom-based patient selection and the experience of the test performer 56
Is monoclonal antibody administration necessary in all vaccinated patients with breakthrough COVID-19 infections? 56
"High" antiretroviral deintensification, a strategy to avoid drug interactions and unfavourable long-term effects of HAART 50
Klebsiella pneumoniae resistant to carbapenems: bloodstream infection prevalence before and during the SARS-CoV-2 pandemic in a tertiary level, North-Eastern Italian Hospital 48
WISE (Web-based Infectious Support for the Elderly) Initiative: Improving Infectious Disease Management in LTCFs―Experience From Northern Italy 48
“Terapia intermittente” con bictegravir/emtricitabina/tenofovir alafenamide in una piccola coorte di pazienti con infezione da HIV, virologicamente soppressi = Short cycle therapy with bictegravir/emtricitabine/tenofovir alafenamide in a small cohort of virally suppressed people living with HIV. 48
Adherence to HAART in HIV 47
Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study 47
Behavioural and demographic correlates of undiagnosed HIV infection in a MSM sample recruited in 13 European cities 45
Acute mediastinitis: a severe complication of transdermal therapy in a patient with ischaemic heart disease. A case report 45
. Raltegravir plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-positive Patients: Safety, Efficacy and Pharmacokinetics 43
Low plasmatic concentration of intensified antiretroviral therapy in a pregnant woman: a case report 43
A reduced dose of darunavir/ritonavir is effective in PI-experienced HIV-infected patients 43
Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients 43
Short-cycle therapy (5 days on/2 days off) with a lamivudine + dolutegravir regimen in a cohort of virologically suppressed patients with HIV infection 40
Rapid radiological improvement of COVID-19 pneumonia after treatment with tocilizumab 40
A Maintenance Dose of Atazanavir/Ritonavir 200/100 mg Once Daily Is Effective in Virologically Suppressed HIV-1–Infected Patients 39
Classical fever of unknown origin in 21 countries with different economic development: an international ID-IRI study 39
Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor 38
Short-Cycle Therapy with Bictegravir/Emtricitabine/Tenofovir Alafenamide in a Small Cohort of Virally Suppressed People Living with HIV: A Long-Term Follow-Up 37
Aetiology of pneumonia following isolated closed head iniury 35
Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona) 34
Antiretroviral therapy in low-resource settings 34
Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients 34
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation 33
Simplification to dual-therapy containing lamivudine and darunavir/ritonavir or atazanavir/ritonavir in HIV-infected patients on virologically suppressive antiretroviral therapy 32
The burden and epidemiology of community-acquired central nervous system infections: a multinational study 32
HIV-1-associated neurocognitive disorders: is HLA-C binding stability to β2-microglobulin a missing piece of the pathogenetic puzzle? 30
HIV and SARS-Coronavirus-2 Epidemics: Possible Interactions and Need for Studies, Especially in Africa 30
Antiretroviral therapy-associated diseases are common in the long-term 29
HIV treatment default in sub-Saharan Africa: issues and possible solutions 29
Cardiovascular Drug Interactions with Nirmatrelvir/Ritonavir for COVID-19: Considerations for Daily Practice. 28
Successful treatment of persistent SARS-CoV-2 infection with nirmatrelvir/ritonavir plus sotrovimab in four immunocompromised patients 28
Patient-centered Care and Treatment in HIV Infection 28
Influenza dell’attività fisica sul valore ematico dei lipidi in una piccola coorte di pazienti che vivono con infezione da HIV, soppressi e dislipidemici, dopo lo switch da un regime contenente tenofovir alafenamide a dolutegravir/rilpivirina = Influence of physical activity level on serum lipid values in a small cohort of suppressed dyslipidemic people living with HIV after switching from a tenofovir alafenamide regimen to dolutegravir/rilpivirine. 28
Dolutegravir monotherapy in HIV-infected naive patients with an HIV-RNA load <100 000 copies/mL: a medium-term follow-up 27
Letter to the Editor: Dolutegravir Monotherapy and Body Weight Gain in Antiretroviral Naïve Patients 27
Disseminated Mycobacterium chimaera infection after open heart surgery in an Italian woman: a case report and a review of the literature 26
HIV-1 RNA levels in semen of people on 'short-cycle' antiretroviral therapy 25
Features of Mpox infection: The analysis of the data submitted to the ID-IRI network 25
HIV serostatus knowledge and serostatus disclosure with the most recent anal intercourse partner in a European MSM sample recruited in 13 cities: results from the Sialon-II study 24
Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients 24
Short-cycle therapy in {HIV}-infected adults: rilpivirine combination 4 days on/3 days off therapy 24
The treatment of latent TB infection in HIV-positive people: the Verona experience 23
Short Cycle, Intermittent Therapy: A Valuable Option in Selected, Virologically Suppressed People Living with HIV 22
Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir 22
Successful Antifungal Combination Therapy and Surgical Approach for Aspergillus fumigatus Suppurative Thyroiditis Associated with Thyrotoxicosis and Review of Published Reports 22
Darunavir/ritonavir 600/100 mg once daily: it's time for larger non-inferiority randomized trials 21
DRIVE-AHEAD Trial's Results and the Need for a More Appropriate Comparator Drug 20
Socio-demographic Characteristics, Sexual and Test-Seeking Behaviours Amongst Men Who have Sex with Both Men and Women: Results from a Bio-behavioural Survey in 13 European Cities 20
Dolutegravir monotherapy: an option for highly adherent HIV1-infected naive patients with relatively low zenith HIV-RNA? 20
Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient 20
Successful Treatment of Castleman's Disease with HAART in two HIV-infected patients. 19
Mycobacterium chimaera infections following cardiac surgery in Italy: results from a National Survey Endorsed by the Italian Society of Cardiac Surgery 19
Tuberculosis-immune reconstitution inflammatory syndrome 19
Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life 18
Optimal fosamprenavir regimen to prevent lipid abnormalities. 17
Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study) 17
Efavirenz dose reduction in HIV-infected patients 17
Dolutegravir Monotherapy's Virological Efficacy in a Highly Treatment-Experienced Patient 16
HIV infection should no longer be detected at late stages in Italy 15
Is there a role for TNF-alpha in HIV1-associated lipodystrophy? 14
Voluntary or Universal HIV testing in Italy? 14
Cutaneous abscess due to Eubacterium lentum in injection drug user: a case report and review of the literature 14
Hyperacute unilateral gonococcal endophtalmitis in an HIV-infected man without genital infection 14
Raltegravir plus lamivudine as 'maintenance therapy' in suppressed HIV-1-infected patients in real-life settings 14
Quantitative Trait Loci for CD4:CD8 Lymphocyte Ratio Are Associated with Risk of Type 1 Diabetes and HIV-1 Immune Control 14
Mediastinal lymphadenitis due to cryptococcal infection in HIV-positive patients on highly active antiretroviral therapy 13
Esophageal Cryptococcosis in a patient with AIDS 13
La riduzione del dosaggio giornaliero di efavirenz nella terapia antiretrovirale: impatto sul budget nell’Azienda Ospedaliera Universitaria Integrata di Verona 13
Hypersensitivity syndrome (DRESS) and meningoencephalitis associated with nevirapine therapy 13
Dolutegravir Monotherapy in HIV-Infected Naive Patients With <100,000 Copies/mL HIV RNA Load 13
Totale 4.323
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.357
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.357
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025302 0 0 0 0 0 0 0 0 1 179 34 88
2025/20264.454 113 157 585 599 621 274 322 220 517 679 190 177
Totale 4.756